TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in human fibrosarcoma cells.

ABSTRACT: Microarray analysis revealed differential gene expression patterns of HT1080 cells treated with various chemical compounds alone and in combination (trabectedin, doxorubicin, mafosfamide, TRAIL, taurolidine) Microarray analysis of HT1080 cells treated with various chemical compounds alone and in combination (trabectedin, doxorubicin, mafosfamide, TRAIL, taurolidine)

ORGANISM(S): Homo sapiens

SUBMITTER: Kamran Harati 

PROVIDER: E-GEOD-32441 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress